Use of Atropine in Tredmill Stress Testing
Primary Purpose
Chest Pain
Status
Completed
Phase
Phase 3
Locations
Israel
Study Type
Interventional
Intervention
Atropine
Sponsored by
About this trial
This is an interventional diagnostic trial for Chest Pain focused on measuring Chest Pain Low work Capacity Rate Incompetence
Eligibility Criteria
Inclusion Criteria:
- Patients with chest pain without evidence of ischemia eligible for exercise test.
- Age> 18 years old
Exclusion Criteria:
Absolute:
- Patients with LBBB
- Unstable Angina
- Recent Myocardial Infarction
- Un controlled Arrythmia
- Congestive heart faliure
- Severe symptomatic valvular heart disease
- Acute Pulmonary Embolism
- Acute perimyocarditis
- Acute aortic dissection
Relative:
- Lt main stenosis
- Severe hypertention (Systolic> 200 mmHg; Diastolic > 100 mmHg)
- Cardiomyopathy
- Obstructiove abnormalities
- Psychiatric disorders
- High degree AV Block
Sites / Locations
- Heart Institute, Ha'Emek Medical Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Placebo Comparator
Active Comparator
Arm Label
1
2
Arm Description
Pateints who achieve target haert rate or conclusive test will not be given Atropine
Patients who won't achieve tarhet heart rate or conclusive results will be given Atropine
Outcomes
Primary Outcome Measures
1- To characterize patients who can't achieve target heart rate at treadmill exercise test.2- To evaluate atropine added during treadmill stress testing in order to increase heart rate and achieave conclusive test.
Secondary Outcome Measures
Full Information
NCT ID
NCT00623207
First Posted
February 14, 2008
Last Updated
July 24, 2015
Sponsor
HaEmek Medical Center, Israel
1. Study Identification
Unique Protocol Identification Number
NCT00623207
Brief Title
Use of Atropine in Tredmill Stress Testing
Official Title
Safety and Feasibility of Atropine Added During Treadmill Stress Testing in Patients With Chronotropic Incompetence or Poor Exercise Capacity.
Study Type
Interventional
2. Study Status
Record Verification Date
July 2015
Overall Recruitment Status
Completed
Study Start Date
December 2007 (undefined)
Primary Completion Date
October 2009 (Actual)
Study Completion Date
October 2009 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
HaEmek Medical Center, Israel
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study is to evaluate the Safety and feasibility of atropine added during treadmill stress testing in patients with chronotropic incompetence or poor exercise capacity.
Our hypothesis is that we can increase heart rate by using atropin in these patients, so we will achieve more conclusive results.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chest Pain
Keywords
Chest Pain Low work Capacity Rate Incompetence
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
103 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Placebo Comparator
Arm Description
Pateints who achieve target haert rate or conclusive test will not be given Atropine
Arm Title
2
Arm Type
Active Comparator
Arm Description
Patients who won't achieve tarhet heart rate or conclusive results will be given Atropine
Intervention Type
Drug
Intervention Name(s)
Atropine
Intervention Description
I.V Atropine 0.5mg up to 2 mg
Primary Outcome Measure Information:
Title
1- To characterize patients who can't achieve target heart rate at treadmill exercise test.2- To evaluate atropine added during treadmill stress testing in order to increase heart rate and achieave conclusive test.
Time Frame
1 yaer
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with chest pain without evidence of ischemia eligible for exercise test.
Age> 18 years old
Exclusion Criteria:
Absolute:
Patients with LBBB
Unstable Angina
Recent Myocardial Infarction
Un controlled Arrythmia
Congestive heart faliure
Severe symptomatic valvular heart disease
Acute Pulmonary Embolism
Acute perimyocarditis
Acute aortic dissection
Relative:
Lt main stenosis
Severe hypertention (Systolic> 200 mmHg; Diastolic > 100 mmHg)
Cardiomyopathy
Obstructiove abnormalities
Psychiatric disorders
High degree AV Block
Facility Information:
Facility Name
Heart Institute, Ha'Emek Medical Center
City
Afula
ZIP/Postal Code
18100
Country
Israel
12. IPD Sharing Statement
Learn more about this trial
Use of Atropine in Tredmill Stress Testing
We'll reach out to this number within 24 hrs